Mark McCamish, Founder of IconOVir Bio

Mark McCamish is the founder of IconOVir Bio. IconOVir Bio has raised $77M in total funding. Latest round: Series A. Based in New York, NY, USA.

About Mark McCamish

Mark McCamish is the President and CEO of IconOVir Bio, a preclinical-stage biotechnology company focused on oncolytic virus therapies. He previously served as President and CEO of Forty Seven, Inc., which was acquired by Gilead for $4.9 billion. He is recognized as an expert in biologic and biosimilars development.

Mark McCamish at a glance

More founders in New York, NY, USA (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library